{
    "organizations": [],
    "uuid": "15f60f6d90bc2b3c95217d613d14d7b262a6473e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sarepta-therapeutics-reports-q1-lo/brief-sarepta-therapeutics-reports-q1-loss-per-share-of-0-28-idUSASC09ZN5",
    "ord_in_thread": 0,
    "title": "Sarepta Therapeutics Reports Q1 Loss Per Share Of $0.28",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 3 (Reuters) - Sarepta Therapeutics Inc:\n* SAREPTA THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT CORPORATE DEVELOPMENTS\n* Q1 NON-GAAP LOSS PER SHARE $0.28\n* Q1 GAAP LOSS PER SHARE $0.55 * SAREPTA THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT CORPORATE DEVELOPMENTS\n* Q1 EARNINGS PER SHARE VIEW $-0.32 â€” THOMSON REUTERS I/B/E/S Source text for Eikon:\nOur ",
    "published": "2018-05-04T05:00:00.000+03:00",
    "crawled": "2018-05-04T17:09:57.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "sarepta",
        "therapeutic",
        "inc",
        "sarepta",
        "therapeutic",
        "announces",
        "first",
        "quarter",
        "financial",
        "result",
        "recent",
        "corporate",
        "development",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "gaap",
        "loss",
        "per",
        "share",
        "sarepta",
        "therapeutic",
        "announces",
        "first",
        "quarter",
        "financial",
        "result",
        "recent",
        "corporate",
        "development",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon"
    ]
}